Theanine is the predominant amino acid of tea that produces calming effects in the brain by increasing levels of serotonin and dopamine, and blocking the binding of L-glutamic acid to glutamate receptors.24-38,68-70 This “feel good” supplement causes no adverse reactions. In fact, in Japan, theanine is added to soft drinks and chewing gum for the purpose of inducing relaxation.
The calming, mood-enhancing effect is achieved by helping to increase alpha-brain waves, electrical brain activity commonly present when you are very relaxed, literally putting you in a better mood.30
Just as meditation, massage or aromatherapy quiets the mind and body, theanine plays a role in inducing the same calm and feeling of well-being without drowsiness. It is a non-toxic, highly desirable mood modulator.
Supplement Facts |
Serving Size 1 vegetarian capsule
|
Amount Per Serving |
L-Theanine
|
100 mg
|
Other ingredients: microcrystalline cellulose, vegetable cellulose (capsule), silica, vegetable stearate.
|
Non-GMO
|
Dosage and Use |
- Take one (1) capsule one to four times daily with or without food, or as recommended by a healthcare practitioner.
|
Warnings
- KEEP OUT OF REACH OF CHILDREN
- DO NOT EXCEED RECOMMENDED DOSE
- Do not purchase if outer seal is broken or damaged.
- When using nutritional supplements, please consult with your physician if you are undergoing treatment for a medical condition or if you are pregnant or lactating.
|
References
1. Physiol Behav. 2011 Jul 25;104(1):76-81.
2. Mol Psychiatry. 2007 Apr;12(4):331-59.
3. Acta Psychiatr Scand. 2011 Dec;124(6):417-26.
4. Neuropsychopharmacology. 2000 Jan;22(1):52-63.
5. CNS Spectr. 2001 Aug;6(8):663-6, 670.
6. Br J Psychiatry 2008 Nov;193(5):383-8.
7. Dialogues Clin Neurosci. 2008;10(2):141-52.
8. Z Kinder Jugendpsychiatr Psychother. 2008 Jan;36(1):27-43.
9. Curr Psychiatry Rep. 2008 Apr;10(2):178-89.
10. Mol Psychiatry. 2010 Jul;15(7):736-47.
11. Curr Pharm Des 2006;12:4613–4623.
12. J Pharm Pharmacol 2008;60:377–384.
13. CNS Neurosci Ther. 2011 Dec;17(6):683-98
14. Int J Essent Oil Ther 2007;1:143–152.
15. Barnes J, Anderson LA, Phillipson JD. Herbal Medicines, 3rd ed. London: Pharmaceutical Press, 2007.
16. Psychosom Med. 2004 Jul-Aug;66(4):607-13
17. Neuropsychopharmacology. 2003 Oct;28(10):1871-81.
18. Phytother Res. 2009 Aug;23(8):1075-81.
19. Pharmacol Biochem Behav. 2002 Jul;72(4):953-64.
20. Indian J Pharmacol. 2012 Mar-Apr; 44(2): 189–192.
21. Curr Pharm Des. 2006;12(35):4613-23.
22. Trends Pharmacol Sci. 2010 Dec;31(12):580-6
23. Pharmacol Biochem Behav. 2009 Jul;93(1):10-6.
24. Biol Psychol. 2007 Jan;74(1):39-45.
25. Journal of Functional Foods, Volume 3, Issue 3, July 2011, Pages 171-178
26. Phytother Res. 2011 Nov;25(11):1636-9.
27. Trends Food Sci Technol 10 (1999), 199–204.
28. J Physiol Anthropol. 2012 Oct 29;31(1):28.
29. Biol Pharm Bull. 2002 Dec;25(12):1513-8.
30. J Herb Pharmacother. 2006;6(2):21-30.
31. Biol Psychol. 2008 Feb;77(2):113-22.
32. Free Radic Biol Med. 2009 Dec 1;47(11):1601-10.
33. Biochem Biophys Res Commun. 2004 Jul 16;320(1):116-22.
34. Neurotoxicology. 2008 Jul;29(4):656-62.
35. J Med Food. 2011 Apr;14(4):334-43.
36. Pharmacol Res. 2011 Aug;64(2):162-8.
37. Biological & Pharmaceutical Bulletin, 25, 1513e1518.
38. LWT - Food Science and Technology 46 (2012) 64e70
39. Int J Neurosci. 1992 Nov-Dec;67(1-4):127-44.
40. Curr Opin Neurobiol. 2013 Feb 2. pii: S0959-4388(13)00027-5.
41. Prog Neurobiol. 2000 Jan;60(1):13-35.
42. J Nutr. 2012 Dec;142(12):2236S-2244S.
43. J Exp Biol. 2002 Dec;205(Pt 23):3679-87.
44. Available at: http://www.tamu.edu/faculty/bmiles/lectures/ amcat.pdf. Accessed February 14, 2013.
45. Amino Acids. 2012 June 8.
46. J Clin Invest. 1999 April 15;103(8):1169–78.
47. Pharmacol Biochem Behav. 2001 Sep;70(1):105-14.
48. Science. 2011 Apr 29;332(6029):604-7.
49. Neuroreport. 2001 Dec 21;12(18):3939-42.
50. Drugs. 1994 Aug;48(2):137-52.
51. J Clin Psychiatry. 2009;70 Suppl 5:18-22..
52. Toxicol Sci. 2010 May;115(1):131-9.
53. World J Gastroenterol. 2010 Mar 21;16(11):1366-76..
54. Am J Clin Nutr. 2002 Nov;76(5):1151S-7S..
55. Psychiatr Pol. 2011 Nov-Dec;45(6):923-31.
56. Mol Cell Proteomics. 2012 Nov;11(11):1274-88.
57. Clin Chem Lab Med. 2012 Aug 24. pii: /j/cclm.ahead-of-print/cclm-2012-0308/cclm-2012-0308.xml.
58. Toxicol Lett. 2012 Aug 3;212(3):320-8
59. Phys Biol. 2008 Dec 19;5(4):044002. doi: 10.1088/1478-3975/5/4/044002.
60. J Nutr Health Aging. 2008 Apr;12(4):252-61.
61. Mol Biol Cell. 2011 Nov;22(21):4192-204.
62. Evidence Report/Technology Assessment: Number 64 S-Adenosyl-L-Methionine for Treatment of Depression, Osteoarthritis, and Liver Disease http://www.ahrq.gov/clinic/epcsums/samesum.htm
63. Proc Nutr Soc. 2011 Nov 4:1-9.
64. J Nutr Health Aging. 2010 Mar;14(3):224-30.
65. Vet Ther. 2008 Summer;9(2):69-82.
66. Metabolism. 2011 May;60(5):673-80.
67. J Alzheimers Dis. 2010;20(4):997-1002.
68. J Sci Food Agric. 2011 Aug 30;91(11):1931-9.
69. Neurochem Res. 1998 May;23(5):667-73.
70. Brain Topogr. 2009 Jun;22(1):44-51.
71. The Open Sleep Journal 2009, 2, 26-32
72. Eur J Nutr. 2005 Mar;44(2):128-32.
73. Hypertens Res. 2011 Sep;34(9):1035-40.
74. Eur J Clin Nutr. 2007 Apr;61(4):536-41.
75. So Ken Study: Effect of Lactium® on sleep disorders. October, 2006.
76. J Dairy Sci. 2000 Jun;83(6):1187-95.
77. Eur J Clin Nutr. 2007 Apr;61(4):536-41.
78. Eur J Nutr. 2005 Mar;44(2):128-32.
79. Curr Med Chem. 2005;12(16):1905-19.
80. Psychiatrike. 2010 Oct-Dec;21(4):332-8.
81. CNS Drugs. 2003;17:539-562.
82. J Ethnopharmacol. 2005 Aug 22;100(1-2):108-13.
83. Pharmacol Res. 2003 Feb;47(2):101-9.
84. Photochem Photobiol. 2011 May-Jun;87(3):680-4.
85. Pharm Biol. 2011 Jan;49(1):46-56.
86. J Nat Prod. 2010 May 28;73(5):1015-21.
87. Arch Gen Psychiatry. 1994 Sep;51(9):687-97.
88.Pharmacol Biochem Behav. 2003 Mar;74(4):877-82.
89. Psychoneuroendocrinology. 2006 May;31(4):473-84.
90. J Agric Food Chem. 2010 May 26;58(10):6387-94.
|
Social Login